title: Treatment of HEV Infection in Patients with a Solid-Organ Transplant and Chronic Hepatitis.
abstract: Hepatitis E virus (HEV) infection can cause hepatic and extra-hepatic manifestations. Treatment of HEV infection has been thoroughly studied in solid-organ-transplant patients who have developed a chronic HEV infection. In this review, we report on our current knowledge regarding treatment of HEV infection.
authors.affiliation: Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse 31059, France. kamar.n@chu-toulouse.fr.|INSERM U1043, IFR-BMT, CHU Purpan, Toulouse 31000, France. kamar.n@chu-toulouse.fr.|University Toulouse III-Paul Sabatier, Toulouse 31000, France. kamar.n@chu-toulouse.fr.
authors.forename: Nassim
authors.initials: N
authors.lastname: Kamar
authors.affiliation: INSERM U1043, IFR-BMT, CHU Purpan, Toulouse 31000, France. lhomme.s@chu-toulouse.fr.|University Toulouse III-Paul Sabatier, Toulouse 31000, France. lhomme.s@chu-toulouse.fr.|Laboratory of Virology, CHU Purpan, Toulouse 31000, France. lhomme.s@chu-toulouse.fr.
authors.forename: Sébastien
authors.initials: S
authors.lastname: Lhomme
authors.affiliation: INSERM U1043, IFR-BMT, CHU Purpan, Toulouse 31000, France. abravanel.f@chu-toulouse.fr.|University Toulouse III-Paul Sabatier, Toulouse 31000, France. abravanel.f@chu-toulouse.fr.|Laboratory of Virology, CHU Purpan, Toulouse 31000, France. abravanel.f@chu-toulouse.fr.
authors.forename: Florence
authors.initials: F
authors.lastname: Abravanel
authors.affiliation: Department of Nephrology and Organ Transplantation, CHU Rangueil, Toulouse 31059, France. marion-olivier@hotmail.fr.|INSERM U1043, IFR-BMT, CHU Purpan, Toulouse 31000, France. marion-olivier@hotmail.fr.
authors.forename: Olivier
authors.initials: O
authors.lastname: Marion
authors.affiliation: University Toulouse III-Paul Sabatier, Toulouse 31000, France. peron.jm@chu-toulouse.fr.|Department of Hepatology, CHU Purpan, Toulouse 31000, France. peron.jm@chu-toulouse.fr.
authors.forename: Jean-Marie
authors.initials: JM
authors.lastname: Peron
authors.affiliation: University Toulouse III-Paul Sabatier, Toulouse 31000, France. alric.l@chu-toulouse.fr.|MR 152 IRD-Toulouse III University, Toulouse 31000, France. alric.l@chu-toulouse.fr.|Internal Medicine-Digestive Department, CHU Purpan, Toulouse, 31000, France. alric.l@chu-toulouse.fr.
authors.forename: Laurent
authors.initials: L
authors.lastname: Alric
authors.affiliation: INSERM U1043, IFR-BMT, CHU Purpan, Toulouse 31000, France. izopet.j@chu-toulouse.fr.|University Toulouse III-Paul Sabatier, Toulouse 31000, France. izopet.j@chu-toulouse.fr.|Laboratory of Virology, CHU Purpan, Toulouse 31000, France. izopet.j@chu-toulouse.fr.
authors.forename: Jacques
authors.initials: J
authors.lastname: Izopet
mesh_terms: D016751:Hepatitis E / Q000188:drug therapy*; D006521:Hepatitis, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D016377:Organ Transplantation / Q000009:adverse effects*; D012254:Ribavirin / Q000627:therapeutic use*; D066027:Transplant Recipients
chemical_list: D012254:Ribavirin; D007372:Interferons
keywords: hepatitis E; immunosuppressants; interferon; ribavirin; sustained virological response